“I would argue, in some respects, the decision the FDA and CDC made here based on six cases out of 7 million [doses distributed] to put a pause on this and take a look at it is an example of the system working the way it should,” Baker said. “In an abundance of caution, they put out the word that, ‘We need to take a look at this,’ and that’s what they’re doing. Baker referred back to an incident earlier this month when problems were reported at a Johnson & Johnson vaccine production site. “I got asked the same question after Baltimore,” Baker said. “Baltimore, to me, is the same thing. It’s pretty clear these guys saw there was an issue, stopped it, ran an investigation. That’s what you want the process to be.”
3 days ago in Local Photo: WHMP
BOSTON (AP) – Gov. Charlie Baker received his COVID-19 vaccine Tuesday. The Republican governor got his first dose of the vaccine at Boston’s Hynes Convention Center at about 2:30 p.m. He received a dose of the Pfizer vaccine. The 64-year-old Baker has repeatedly said he would not move to the head of the vaccination line and would wait until he was eligible under federal guidelines. Baker said he preregistered and was notified last week that he could receive the vaccine. Baker said the vaccine is key to ending the pandemic and he’ll return to the Hynes to receive his second shot.
Mistake at Baltimore plant won t impact current COVID-19 vaccine appointments in Mass., state says Share Updated: 11:00 PM EDT Mar 31, 2021 Share Updated: 11:00 PM EDT Mar 31, 2021
Hide Transcript
TRACKING THE COVID-19 VACCINE Share Updated: 11:00 PM EDT Mar 31, 2021 There is new doubt about a major COVID-19 vaccine boost that was celebrated by Massachusetts Gov. Charlie Baker on Wednesday.Just hours after Baker celebrated the anticipated arrival of more than 100,000 doses of the single-shot Johnson & Johnson vaccine in the state next week, The New York Times reported that workers at Emergent BioSolutions Baltimore plant accidentally conflated vaccine ingredients several weeks ago, spoiling about 15 million doses of the J&J COVID-19 vaccine in the process.The mixup, which federal officials chalked up to human error, forced regulators to delay authorization of Emergent s production lines and halted future shipments of Johnson & Johnson doses i